Meropenem trihydrate is an antibiotic of the carbapenem class that is used to treat a wide range of bacterial infections. It is effective against Gram-negative and Gram-positive bacteria as well as some anaerobes. It is a broad-spectrum antibiotic used to treat serious infections caused by multidrug-resistant microorganisms. It is a sterile, white to off-white, odorless or nearly odorless, crystalline powder.
Meropenem trihydrate is used to treat severe, complicated, or life-threatening bacterial infections of the lungs, urinary tract, skin, soft tissue, and gynecologic infections, septicemia, and meningitis in adults and children.
Meropenem trihydrate works by inhibiting the synthesis of the bacterial cell wall, which ultimately leads to cell death. It binds to several penicillin-binding proteins and acts as a competitive inhibitor, limiting the actions of enzymes necessary for the formation of the bacterial cell wall.
The therapeutic effects of meropenem trihydrate can be seen within 1-2 days of starting the antibiotic. However, it can take up to 7-10 days to achieve a full cure.
Meropenem trihydrate is rapidly and completely absorbed, reaching peak concentrations in the blood within 1 to 2 hours.
Meropenem trihydrate is primarily eliminated through the kidneys via glomerular filtration and tubular secretion. Approximately 50-70% of the drug is eliminated unchanged in the urine.
The recommended dose of meropenem trihydrate for adults and children is 500-1000 mg intravenously administered every 8 hours. Dosages should be adjusted for patients with kidney or liver impairment.
Meropenem trihydrate is usually given intravenously every 8 hours over 30 minutes to 60 minutes. For mild or moderate bacterial infections, a single oral dose may be administered.
Common side effects of meropenem trihydrate include headache, diarrhea, nausea, vomiting, abdominal pain, rash, dizziness and convulsions. Rare side effects include kidney damage, anaphylactic shock, and liver damage.
The LD50 of meropenem trihydrate is not known. Overdose of meropenem trihydrate may cause serious side effects including severe allergic reactions, kidney damage, anaphylactic shock, and liver damage.
Meropenem trihydrate should not be used in patients with a history of anaphylactic shock or hypersensitivity to meropenem or any other drug within the carbapenem class. Meropenem trihydrate can also interact with other medications, so patients should inform their doctor of all medications they are taking before using this medication.
Meropenem trihydrate may interact with other medications, including antibiotics, cephalosporins, diuretics, and probenecid. It also may interact with vitamins, herbal supplements, and over-the-counter medications.
Meropenem trihydrate may interact with certain diseases or medical conditions, such as kidney or liver impairment, drug allergies, sickle cell anemia. Patients with such conditions should inform their doctor before using this medication.
Drug interactions with meropenem trihydrate may occur when taken with other medications, such as antibiotics, cephalosporins, diuretics, and probenecid. Patients should inform their doctor of any other medications they are taking before starting treatment with this medication.
No food interactions with meropenem trihydrate have been reported. Patients should discuss with their doctor any dietary changes or restrictions before starting treatment.
Safety and efficacy of meropenem trihydrate in pregnant women have not been established. Women who are pregnant or planning to become pregnant should consult with their healthcare provider before taking this medication.
It is not known whether meropenem trihydrate is excreted in breast milk. Women who are breastfeeding should consult with their doctor or healthcare provider before taking this medication.
Symptoms of an overdose include anaphylaxis, convulsions, and nephrotoxicity. Treatment involves supportive care and drug treatment as appropriate. Dialysis may be necessary in severe cases.
Meropenem trihydrate is contraindicated in patients with a history of anaphylactic shock or hypersensitivity to meropenem or any other drug within the carbapenem class. It should also not be used in pregnant or breastfeeding women or patients with kidney or liver problems.
Meropenem trihydrate should be taken exactly as prescribed by your doctor. Do not take more or less than prescribed or for longer or shorter than prescribed. The medication should be taken at evenly spaced intervals. Make sure to drink ample amounts of fluids during treatment.
Meropenem trihydrate should be stored at room temperature between 15-30℃ in a tightly sealed container, away from light and moisture. Keep out of reach of children.
The volume of distribution of meropenem trihydrate is 0.4 to 0.9 L/kg, which indicates that the drug is widely distributed in the body.
The elimination half-life (t½) of meropenem trihydrate is approximately 1.5-2 hours, which is relatively short compared to other antibiotics.
The average systemic clearance of meropenem trihydrate is 0.25 to 0.5 L/kg/hour. The clearance is higher in patients with normal renal function than those with impaired renal function.
See in details version Meropenem Trihydrate also Meropenem Trihydrate in bangla